pharmacopeia
GET
/api/v1/drug/docusate

Mechanism of action

Sourced from openFDA

Mechanism-of-action class: Surfactant Activity.

Indications

Sourced from openFDA
  • Uses for relief of occasional constipation and irregularity this product generally produces bowel movement in 12 to 72 hoursICD-10: K59.00

Dosage & administration

Sourced from openFDA

Directions take with a glass of water adults and children 12 years and over take 1-3 softgels daily. This dose may be taken as a single daily dose or in divided doses. children 2 to under 12 years of age take 1 softgel daily children under 2 years ask a doctor

Warnings & precautions

Sourced from openFDA

Do not use if you are presently taking mineral oil, unless told to do so by a doctor. Ask a doctor before use if stomach pain nausea vomiting noticed a sudden change in bowel habits that lasts over 2 weeks Stop use and ask a doctor if you have rectal bleeding or no bowel movement after using a laxative. These could be a sign of a serious condition. you need to use a laxative for more than 1 week If pregnant or breast-feeding, ask a health care professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center (1-800-2222-1222) right away.

FAERS reports

View JSON
Reference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. Counts reflect reporting volume — how often a reaction was reported, not how often it occurs. For decision-grade use, consult openFDA and the FAERS Public Dashboard directly.
61,797 total reports matchedLatest report Share = reports listing the reaction ÷ total matched reports. Rows can sum to >100% because a single report often lists multiple reactions.
  1. 1Fatigue5,2288.5%
  2. 2Nausea4,9238.0%
  3. 3Dyspnoea3,8246.2%
  4. 4Diarrhoea3,8026.2%
  5. 5Constipation3,7536.1%
  6. 6Death3,4725.6%
  7. 7Pain3,4315.6%
  8. 8Vomiting3,0915.0%
  9. 9Asthenia3,0675.0%
  10. 10Fall3,0504.9%
  11. 11Pneumonia2,9114.7%
  12. 12Headache2,7264.4%
  13. 13Off Label Use2,6744.3%
  14. 14Dizziness2,5264.1%
  15. 15Drug Ineffective2,4884.0%

Literature

View JSON

Recent PubMed references pinned to Docusate as a MeSH major topic. Citations link to pubmed.ncbi.nlm.nih.gov.

Clinical trials

View JSON

The 10 most recently updated of 63 ClinicalTrials.gov registrations naming Docusate as an intervention. Registration is not evidence of efficacy or safety — reference crosswalk only.

Frequently asked questions

How does Docusate work?
Mechanism-of-action class: Surfactant Activity.
What is Docusate used for?
According to FDA labeling, Docusate carries indications including: Uses for relief of occasional constipation and irregularity this product generally produces bowel movement in 12 to 72 hours. This is a reference summary of labeled uses, not medical advice or a treatment recommendation.
What class of drug is Docusate?
Docusate is classified as Surfactant Activity, Increased Large Intestinal Motility, Stimulation Large Intestine Fluid/Electrolyte Secretion.
What are the brand names for Docusate?
Docusate is marketed under brand names including Colace, Colace w/Sennosides, DOK, Doculase, Docusol, Enemeez, Enemeez Plus, Ferralet 90.
Note. Data for docusate is illustrative MVP content compiled from public sources. pharmacopeia is for educational and informational use only and is not a substitute for professional medical advice.

Search pharmacopeia

Search drugs, classes, and ingredients